Fennec Pharmaceuticals Inc (FENC) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.00x

Fennec Pharmaceuticals Inc (FENC) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.49 Million. Explore Fennec Pharmaceuticals Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$1.49 Million
USD

Capital Expenditures

$0.00
USD

Fennec Pharmaceuticals Inc Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Fennec Pharmaceuticals Inc across 1 annual periods. Also explore Fennec Pharmaceuticals Inc assets under control for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Fennec Pharmaceuticals Inc (2024–2024)

Year-by-year capital reinvestment analysis for Fennec Pharmaceuticals Inc. For live market cap and broader valuation context, see Fennec Pharmaceuticals Inc stock valuation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 0.00x $0.00 $26.98 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow